Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Category: Pharma applications

June 3, 2026 CD as API / CD derivatives / Drug delivery / Pharma applications

Nano-Enabled Toxicity of Pharmaceutical Excipients

Nanotechnology has brought revolutionary advances in the pharmaceutical field. Among drug delivery systems, nanocarriers, which enhance the solubility, stability and

Continue reading

June 1, 2026 Drug delivery / Pharma applications

Biphasic dissolving microneedles with cyclodextrin inclusion complexes for enhanced delivery of poorly soluble drugs

Dissolving microneedles (DMNs) have been widely investigated for transdermal drug delivery, yet their clinical translation and commercialization remain limited, primarily

Continue reading

May 29, 2026 Drug delivery / Pharma applications / Uncategorized

CD-based supramolecular polymers based on host–guest interactions for cancer therapy

Cyclodextrin-based supramolecular polymers (SPCDs) have emerged as promising platforms for cancer therapy via the utilization of cyclodextrin (CD)-mediated host-guest interactions

Continue reading

May 28, 2026 CD derivatives / Drug delivery / Pharma applications / Uncategorized

PEG-β-Cyclodextrin polymer-based formulation to increase the antiangiogenic activity of rutin in vivo

Rutin (RTN) is a natural flavonoid with well-documented anti-angiogenic, antioxidant, anti-inflammatory, and anti-cancer properties. However, its therapeutic potential is limited

Continue reading

May 27, 2026 CD as API / Pharma applications

Cyclarity Unveils First-Ever Clinical Data Demonstrating Excretion of Oxidized Cholesterol, at American Heart Association Vascular Discovery Scientific Sessions

 Cyclarity Therapeutics, Inc., a clinical stage biopharmaceutical company engineering cyclodextrin molecules into simple, scalable, and affordable therapies that bind and

Continue reading

May 25, 2026 CD as API / Pharma applications

CDs as Modulators of Regulated Cell Death: Implications for Immunometabolism and Therapeutic Innovation

This review critically examines how cyclodextrins modulate regulated cell death pathways and the implications for immunometabolism and therapeutic translation. Increasing

Continue reading

May 18, 2026 CD as API / Pharma applications

HPBCD against acute and subacute infarcts in a mouse model of ischemic stroke

HPβCD has also been investigated as an active pharmaceutical ingredient (API) for the prospective treatment of ischemic stroke. We previously

Continue reading

May 13, 2026 Drug delivery / Environmental / Food / Uncategorized

Structural diversity of cyclodextrin metal-organic frameworks enables their diverse applications

Cyclodextrin-based metal-organic frameworks (CD-MOFs) constitute a distinctive family of porous solids that combine the modularity of coordination networks with the

Continue reading

May 12, 2026 Drug delivery / Pharma applications

Exploring Cyclodextrin-Based MOFs for Drug Delivery: Synthesis, Applications, and Future Perspectives

3D cyclodextrin-based metal-organic frameworks (CD-MOFs) have emerged as a biocompatible alternative to conventional MOFs, as they are synthesized using safer,

Continue reading

May 11, 2026 CD as API / CD derivatives / Drug delivery / Pharma applications

Sugammadex analog water soluble BCD polymer for peptide complexes

In this work, an integrated biophysical and biological study is presented describing both the structural and biological features of the

Continue reading

Posts pagination

«Previous Posts 1 2 3 4 … 128 Next Posts»

Recent Posts

  • Call for Chapters: Cyclodextrins in Phytomedicine
  • Poly-CD-PEG-camptothecin Combined with Olaparib  in People With Relapsed/​Refractory Small Cell Lung Cancer (Clinical trial)
  • Alkali Metal Adduct Formation in Cyclic Ion Mobility-Mass Spectrometry of O-Methylated Cyclodextrin Isomers
  • Doxycycline release from cyclodextrin oligomer-containing collagen gels
  • Cyclodextrin-based polymer materials and their applications – A review covering a 20-year period

Tags

alpha-CD Alzheimer disease atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (27)
  • Analysis (70)
  • CD as API (347)
  • CD derivatives (414)
  • Cosmetics and toilettry (52)
  • Diagnosis (12)
  • Drug delivery (797)
  • E-ducation (63)
  • Environmental (135)
  • Events (234)
  • Food (225)
  • Gene delivery (20)
  • Household products (1)
  • Household products (4)
  • In Hungarian (4)
  • Life sciences (43)
  • Non-pharma applications (403)
  • Other industrial use (107)
  • Pharma applications (1,189)
  • Supramolecular systems (40)
  • Uncategorized (152)

Top Posts

  • Call for Chapters: Cyclodextrins in Phytomedicine
  • Alkali Metal Adduct Formation in Cyclic Ion Mobility-Mass Spectrometry of O-Methylated Cyclodextrin Isomers
  • Poly-CD-PEG-camptothecin Combined with Olaparib  in People With Relapsed/​Refractory Small Cell Lung Cancer (Clinical trial)
  • Cyclodextrins for Chemosensing - Book
  • Call for Book Chapters: Cyclodextrin Systems for Green Hydrogen Production
  • A Cyclodextrin Surprise in a Japanese Supplement
  • Cyclodextrin-based polymer materials and their applications - A review covering a 20-year period
  • GRAS status of CD derivatives
  • Doxycycline release from cyclodextrin oligomer-containing collagen gels
  • Methyl salicylate/methyl-β-cyclodextrin inclusion complex modulates plant defense against cold and heat stress

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,474 other subscribers

Loading Comments...